Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 5 | $208,889 |
| Sells | 2 | $8,138 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 17 Mar 2025 19:07 | ATYR | aTYR PHARMA INC | GROSS JANE A | Director | 17 Mar 2025 | Purchase | 3,750 | 4 | 15,000 | D |
| 04 Feb 2025 18:14 | ATYR | aTYR PHARMA INC | BROADFOOT JILL MARIE | Chief Financial Officer | 04 Feb 2025 | Sale | 1,254 | 3.78 | 4,740 | D |
| 04 Feb 2025 18:11 | ATYR | aTYR PHARMA INC | DENYES NANCY | General Counsel | 04 Feb 2025 | Sale | 899 | 3.78 | 3,398 | D |
| 24 Jul 2024 17:29 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Director | 24 Jul 2024 | Purchase | 52,300 | 1.9319 | 101,038 | I |
| 24 Jul 2024 17:29 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Director | 23 Jul 2024 | Purchase | 6,648 | 1.8163 | 12,075 | I |
| 24 Jul 2024 17:29 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Director | 22 Jul 2024 | Purchase | 41,052 | 1.7417 | 71,500 | I |
| 06 Jun 2024 08:26 | ATYR | aTYR PHARMA INC | DENYES NANCY | General Counsel | 05 Jun 2024 | Purchase | 5,000 | 1.8552 | 9,276 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)